Venture Capital

Aperture Venture Capital

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO

Geographical Focus
United States

Industries Focus

  • Technology
  • FinTech
  • Enterprise Software

Investor Details Founded: 2012

Aperture Venture Capital is a seed-stage venture firm investing in diverse founders building the future of fintech and enterprise software. The firm focuses on early-stage investments in technology companies across various sectors, aiming to support emerging businesses and technologies through tailored financial solutions and expert guidance. Aperture Venture Capital is committed to fostering innovation and growth by partnering with exceptional entrepreneurs to build innovative companies in the fintech and enterprise software sectors. The firm's investment strategy emphasizes collaboration and partnership to drive growth and success in the ventures they support. Aperture Venture Capital has invested in several companies that have achieved valuations exceeding $1 billion, demonstrating its successful track record in identifying and nurturing high-potential startups. The firm's approach is designed to provide portfolio companies with a winning edge in today's competitive landscape by partnering with industry-leading corporations, thereby amplifying their bottom line over time. Aperture Venture Capital's investors include leading corporations, endowments, and other institutions committed to building an inclusive economy through partnership and collaboration. The firm's engagement model, known as the Diversity Investing API℠, unlocks critical operating resources for its portfolio companies while helping its corporate partners access a pipeline of diverse talent and market innovations. This innovative model addresses systemic biases in venture capital by providing scalable solutions to support diverse founders and companies. Aperture Venture Capital's commitment to diversity and inclusion is evident in its investment approach and the composition of its portfolio, reflecting a dedication to fostering a more inclusive and equitable entrepreneurial ecosystem. The firm's focus on diverse founders and companies aligns with its mission to build the next generation of game-changing tech companies, contributing to a more inclusive and innovative economy. Aperture Venture Capital's strategic partnerships with industry leaders and its unique investment model position it as a significant player in the venture capital landscape, driving meaningful impact and supporting the growth of diverse and innovative companies across the United States. The firm's dedication to diversity, innovation, and collaboration underscores its role in shaping the future of fintech and enterprise software, making it a valuable partner for entrepreneurs and investors alike. Aperture Venture Capital continues to seek out and support exceptional entrepreneurs, leveraging its resources and expertise to help them realize their potential and achieve success in the competitive tech industry. The firm's ongoing commitment to diversity and inclusion ensures that it remains at the forefront of fostering innovation and growth in the venture capital sector, contributing to a more inclusive and dynamic entrepreneurial ecosystem. Aperture Venture Capital's proactive approach to addressing systemic biases in venture capital and its focus on diverse founders and companies reflect a forward-thinking and socially responsible investment philosophy, setting a positive example for the industry and paving the way for future generations of entrepreneurs.

Requirements
  • Diverse founders
  • Fintech and enterprise software focus
  • Early-stage companies
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Inspire Medical
  • Axonics
  • Biohaven Pharmaceuticals
  • Tarsus Pharmaceuticals
  • MAKO Surgical
  • V-Wave
  • Cameron Health
  • Conor Medsystems
  • Trevi Therapeutics
  • Collegium Pharmaceutical
  • Aclaris Therapeutics
Claim this Investor

Are you an official representative of Aperture Venture Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim